Technical Articles
FGF19
FGFR4: Why Hepatocellular Carcinoma Targeting Focuses on This Selective Receptor
Among the four FGFR family members, FGFR4 alone resides in the liver and binds the KLB co-receptor. From an industry perspective, this article dissects the FGF19 axis, its association with hepatocellular carcinoma and the design logic of selective in
View details
- Signaling Pathway
- FGFR4
- Hepatocellular carcinoma
- FGF19
- Selective inhibitor
- Targeted therapy
- UA011375
A Door That Needs Two Keys: How FGF19, FGFR4 and KLB Open the Gate
The FGFR4 door opens only when both keys—FGF19 and KLB—are inserted at the same time. This article walks through the four-step assembly of the FGF19-FGFR4-KLB ternary complex and the full process of signal entry.
View details
- Signaling Pathway
- FGFR4
- FGF19
- Beta-Klotho
- KLB
- Ternary complex
- Hepatocellular carcinoma
- UA011375
- 1














